{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:24:23Z","timestamp":1783607063744,"version":"3.55.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008081","name":"Dystrophic Epidermolysis Bullosa Research Association","doi-asserted-by":"publisher","award":["JONKMAN 1"],"award-info":[{"award-number":["JONKMAN 1"]}],"id":[{"id":"10.13039\/100008081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Patients with the genetic blistering skin condition epidermolysis bullosa (EB) report severe pain as a consequence of skin and mucous membrane lesions including blisters, wounds, and scars. Adequate symptom alleviation is not often achieved using conventional pharmacologic interventions. Finding novel approaches to pain care in EB is imperative to improve the quality of life of patients living with EB. There are several anecdotal reports on the use of cannabinoid-based medicines (CBMs) by EB patients to reduce the burden of symptoms. However, controlled clinical investigations assessing these reported effects are lacking. As the pain quality \u201cunpleasantness\u201d delineates EB pain, we hypothesize the modulation of affective pain processing in the brain by way of intervention with CBMs comprising the cannabinoids \u0394-9-tetrahydrocannabinol and cannabidiol\u2014objectified by functional magnetic resonance imaging (fMRI). The C4EB study is an investigator-initiated, single-centre, randomized, double-blind, placebo-controlled and crossover trial. Adult patients with the diagnosis epidermolysis bullosa, reporting chronic pain will be eligible to participate. Following baseline measurements, participants will be randomized to receive the sublingually administered interventions placebo and Transvamix<jats:sup>\u00ae<\/jats:sup> in forward or reversed orders, each for two weeks and separated by a washout. The primary outcome is the difference in numeric rating scale pain scores between grouped interventions, using affective descriptors within the Short-form McGill Pain Questionnaire-2. Secondary outcomes include pain self-efficacy, concomitant analgesic medication-use and adverse events. Additionally, fMRI will be employed to assess brain connectivity related to neuroanatomic pain circuits at baseline, placebo and Transvamix<jats:sup>\u00ae<\/jats:sup> interventions. The study was approved by the ethical committee at the University Medical Center of Groningen in the Netherlands. Results will be submitted for publication in a peer-reviewed journal.<\/jats:p>\n<jats:p><jats:bold>Trial registration number<\/jats:bold>: Netherlands Trial Register: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.who.int\/clinical-trials-registry-platform\/network\/primary-registries\/netherlands-trial-registry-(ntr)\" xlink:type=\"simple\">NL9347<\/jats:ext-link> (Acronym: C4EB).<\/jats:p>","DOI":"10.1371\/journal.pone.0277512","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T18:28:54Z","timestamp":1670869734000},"page":"e0277512","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["The C4EB study\u2014Transvamix (10% THC \/ 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-7097","authenticated-orcid":true,"given":"Nicholas H. B.","family":"Schr\u00e4der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Duipmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco J.","family":"Renken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8848-5158","authenticated-orcid":true,"given":"Peter","family":"S\u00f6r\u00f6s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Bolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 P.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"pone.0277512.ref001","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2340\/00015555-1758","article-title":"Health-related quality of life in epidermolysis bullosa: Validation of the dutch QOLEB questionnaire and assessment in the dutch population.","volume":"94","author":"WY Yuen","year":"2014","journal-title":"Acta Derm Venereol."},{"key":"pone.0277512.ref002","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jdv.17012","article-title":"Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed?","volume":"35","author":"R Baardman","year":"2021","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"pone.0277512.ref003","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12916-014-0178-2","article-title":"Pain care for patients with epidermolysis bullosa: Best care practice guidelines","volume":"12","author":"KR Goldschneider","year":"2014","journal-title":"BMC Med"},{"key":"pone.0277512.ref004","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-01403-x","article-title":"Emergency management in epidermolysis bullosa: Consensus clinical recommendations from the European reference network for rare skin diseases.","volume":"15","author":"JE Mellerio","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"pone.0277512.ref005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13023-017-0666-5","article-title":"Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex","volume":"12","author":"J Brun","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0277512.ref006","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4306\/pi.2017.14.6.746","article-title":"Pain in patients with dystrophic epidermolysis bullosa: Association with anxiety and depression","volume":"14","author":"G Fortuna","year":"2017","journal-title":"Psychiatry Investig"},{"key":"pone.0277512.ref007","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2340\/00015555-2827","article-title":"Pain quality assessment scale for epidermolysis bullosa","volume":"98","author":"NHB Schr\u00e4der","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"pone.0277512.ref008","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2147\/JPR.S60433","article-title":"Brain imaging of pain: State of the art","volume":"9","author":"DL Morton","year":"2016","journal-title":"J Pain Res"},{"key":"pone.0277512.ref009","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.pmrj.2011.05.018","article-title":"Central nervous system reorganization in a variety of chronic pain states: A review","volume":"3","author":"DE Henry","year":"2011","journal-title":"PM R"},{"key":"pone.0277512.ref010","first-page":"8","article-title":"The anterior cingulate cortex and pain processing","author":"PN Fuchs","year":"2014","journal-title":"Front Integr Neurosci"},{"key":"pone.0277512.ref011","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and Pain: A Clinical Review.","volume":"2","author":"KP Hill","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"pone.0277512.ref012","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2012.00009","article-title":"The endocannabinoid system: An overview","volume":"6","author":"N Battista","year":"2012","journal-title":"Front Behav Neurosci"},{"key":"pone.0277512.ref013","volume-title":"WHO Expert Committee on Drug Dependence. Delta-9-tetrahydrocannabinol","author":"Who","year":"2018"},{"key":"pone.0277512.ref014","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1155\/2005\/169093","article-title":"Preclinical science regarding cannabinoids as analgesics: An overview","author":"ME Lynch","year":"2005","journal-title":"Pain Research and Management"},{"key":"pone.0277512.ref015","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"M Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"pone.0277512.ref016","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pain.2012.09.017","article-title":"Amygdala activity contributes to the dissociative effect of cannabis on pain perception","volume":"154","author":"MC Lee","year":"2013","journal-title":"Pain"},{"key":"pone.0277512.ref017","doi-asserted-by":"crossref","first-page":"E1285","DOI":"10.1212\/WNL.0000000000006293","article-title":"Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity","volume":"91","author":"L Weizman","year":"2018","journal-title":"Neurology"},{"key":"pone.0277512.ref018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.10.006","article-title":"The neuropsychopharmacology of cannabis: A review of human imaging studies","volume":"195","author":"MAP Bloomfield","year":"2019","journal-title":"Pharmacol Ther"},{"key":"pone.0277512.ref019","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"EB Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"pone.0277512.ref020","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: No \u201cStrain,\u201d no gain.","volume":"9","author":"EB Russo","year":"2019","journal-title":"Front Plant Sci"},{"key":"pone.0277512.ref021","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.","volume":"66","author":"B Russo","year":"2006","journal-title":"Med Hypotheses."},{"key":"pone.0277512.ref022","article-title":"Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study.","volume":"16","author":"NHB Schr\u00e4der","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"pone.0277512.ref023","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bjd.17619","article-title":"Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa","volume":"180","author":"AE Martinez","year":"2019","journal-title":"Br J Dermatol"},{"key":"pone.0277512.ref024","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis.","volume":"313","author":"PF Whiting","year":"2015","journal-title":"JAMA"},{"key":"pone.0277512.ref025","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","article-title":"Efficacy of cannabis-based medicines for pain management: A systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"J Aviram","year":"2017","journal-title":"Pain Physician"},{"key":"pone.0277512.ref026","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","article-title":"Plasma cannabinoid pharmacokinetics following controlled oral \u0394 9-tetrahydrocannabinol and oromucosal cannabis extract administration","volume":"57","author":"EL Karschner","year":"2011","journal-title":"Clin Chem"},{"key":"pone.0277512.ref027","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1300\/J175v03n04_02","article-title":"A phase I, double blind, three-way crossover study to assess the pharmacokinetic profile of Cannabis Based Medicine Extract (CBME) administered sublingually in variant cannabinoid ratios in normal healthy male volunteers (GWPK0215).","volume":"3","author":"GW Guy","year":"2003","journal-title":"J Cannabis Ther"},{"key":"pone.0277512.ref028","unstructured":"Geneesmiddelen Informatieblad\u2014Bijsluiter Cannabis Olie Transvaal Apotheek. 2019. Available: https:\/\/www.transvaalapotheek.nl\/wp-content\/uploads\/2018\/05\/BIJSL-Cannabis-olie-19.pdf"},{"key":"pone.0277512.ref029","unstructured":"Medicinale cannabis minder dan 50.000 keer verstrekt. In: Stichting Pharmaceutisch Kerngetallen [Internet]. 2019 pp. 51\u20132. Available: https:\/\/www.sfk.nl\/publicaties\/PW\/2019\/medicinale-cannabis-minder-dan-50-000-keer-verstrekt"},{"key":"pone.0277512.ref030","unstructured":"Bijwerkingcentrum Lareb. Overview of Reports Submitted to Lareb: Cannabinoids (droplet form). 2021 [cited 24 Nov 2021]. Available: https:\/\/www.lareb.nl\/nl\/databank\/result?formGroup=&atc=N02BG10&drug=CANNABIDIOL%2FDRONABINOL"},{"key":"pone.0277512.ref031","article-title":"The REDCap consortium: Building an international community of software platform partners","author":"PA Harris","year":"2019","journal-title":"Journal of Biomedical Informatics"},{"key":"pone.0277512.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"pone.0277512.ref033","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.neuroimage.2011.12.028","article-title":"Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI.","volume":"60","author":"P Kundu","year":"2012","journal-title":"Neuroimage."},{"key":"pone.0277512.ref034","article-title":"Identifying epidermolysis bullosa patient needs and perceived treatment benefits: An explorative study using the patient benefit index.","volume":"10","author":"NHB Schr\u00e4der","year":"2021","journal-title":"J Clin Med."},{"key":"pone.0277512.ref035","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1073\/pnas.1301725110","article-title":"Integrated strategy for improving functional connectivity mapping using multiecho fMRI","volume":"110","author":"P Kundu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0277512.ref036","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/brain.2012.0073","article-title":"Conn: A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks","volume":"2","author":"S Whitfield-Gabrieli","year":"2012","journal-title":"Brain Connect"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T18:29:09Z","timestamp":1670869749000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277512"}},"subtitle":[],"editor":[{"given":"Steven Eric","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277512","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]}}}